000 | 01133 a2200301 4500 | ||
---|---|---|---|
005 | 20250516113539.0 | ||
264 | 0 | _c20121211 | |
008 | 201212s 0 0 eng d | ||
022 | _a1474-1784 | ||
024 | 7 |
_a10.1038/nrd3794 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiossec, Pierre | |
245 | 0 | 0 |
_aTargeting IL-17 and TH17 cells in chronic inflammation. _h[electronic resource] |
260 |
_bNature reviews. Drug discovery _cOct 2012 |
||
300 |
_a763-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aInterleukin-17 _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Interleukin-17 _xantagonists & inhibitors |
650 | 0 | 4 |
_aTh17 Cells _xdrug effects |
700 | 1 | _aKolls, Jay K | |
773 | 0 |
_tNature reviews. Drug discovery _gvol. 11 _gno. 10 _gp. 763-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrd3794 _zAvailable from publisher's website |
999 |
_c22146396 _d22146396 |